#BEGIN_DRUGCARD DB02205

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C19H22O4

# Chemical_IUPAC_Name:
(7S)-7-(2-hydroxypropan-2-yl)-3-(2-methylbut-3-en-2-yl)-2H,6H,7H-furo[3,2-g]chromen-2-one

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One

# HET_ID:
BRZ

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C19H22O4/c1-6-18(2,3)13-8-11-7-12-9-16(19(4,5)21)22-14(12)10-15(11)23-17(13)20/h6-8,10,16,21H,1,9H2,2-5H3/t16-/m0/s1

# InChI_Key:
InChIKey=JCDLLLXYAICSQV-INIZCTEOSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2205

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
314.3756

# Molecular_Weight_Mono:
314.151809192

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1K3T

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
3.54

# Predicted_LogS:
-4.2

# Predicted_Water_Solubility:
2.20e-02 g/l

# Primary_Accession_No:
DB02205

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5287846

# PubChem_Substance_ID:
46505661

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00760

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@]1(CC2=C(O1)C=C1OC(=O)C(=CC1=C2)C(C)(C)C=C)C(C)(C)O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:54 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Glycosome

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X52898

# Drug_Target_1_GenBank_ID_Protein:
10609

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>1080 bp
ATGCCCATCAAGGTCGGTATCAACGGCTTTGGCCGCATCGGACGCATGGTCTTTCAGGCC
TTGTGTGAGGACGGCCTTCTCGGGACGGAGATTGACGTCGTGGCGGTGGTCGATATGAAC
ACGGATGCCGAGTACTTTGCGTACCAGATGCGTTACGACACCGTGCATGGCAAGTTCAAG
TACGAGGTGACGACGACGAAGAGCAGCCCCTCCGTTGCGAAGGACGACACGCTTGTGGTG
AATGGCCACCGTATCCTGTGCGTGAAGGCGCAGCGGAACCCGGCGGATCTCCCATGGGGC
AAGCTTGGTGTGGAGTACGTAATTGAATCAACGGGCCTGTTCACCGCCAAGGCGGCGGCG
GAGGGCCACCTGCGCGGCGGTGCACGGAAGGTCGTCATCAGCGCTCCCGCCTCTGGTGGC
GCCAAGACACTTGTGATGGGCGTGAACCATCACGAGTACAACCCCAGTGAGCACCACGTT
GTGTCTAACGCGTCATGCACGACCAATTGCCTTGCGCCCATTGTGCACGTCCTGGTGAAG
GAGGGATTCGGCGTGCAGACCGGCCTCATGACGACGATCCACTCGTACACAGCAACGCAG
AAGACGGTGGACGGTGTGTCGGTGAAGGACTGGCGTGGCGGTCGTGCGGCTGCTGTCAAC
ATCATTCCGAGCACGACTGGTGCGGCGAAGGCGGTGGGCATGGTGATTCCGAGCACCCAG
GGCAAGCTGACGGGCATGTCTTTTCGTGTCCCCACCCCGGACGTGTCCGTGGTGGATCTC
ACCTTCACTGCGGCGCGCGACACCAGCATACAGGAGATCGACGCCGCCCTGAAGCGCGCG
TCTAAGACTTACATGAAAGGAATTCTCGGCTACACGGACGAGGAGCTTGTGAGTGCAGAC
TTCATTAATGACAACCGCAGCTCCATTTACGACTCCAAGGCAACGCTGCAGAACAACCTG
CCGAAGGAGCGCCGCTTCTTCAAGATTGTGTCGTGGTACGACAACGAGTGGGGATACTCC
CACCGCGTGGTGGACCTTGTACGCCACATGGCCTCGAAGGATCGTTCGGCAAGGTTGTAG

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
2167831	Kendall G, Wilderspin AF, Ashall F, Miles MA, Kelly JM: Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase does not conform to the 'hotspot' topogenic signal model. EMBO J. 1990 Sep;9(9):2751-8.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2799

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
39061

# Drug_Target_1_Name:
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal

# Drug_Target_1_Number_of_Residues:
359

# Drug_Target_1_PDB_ID:
1QXS

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00044	Gp_dh_N
PF02800	Gp_dh_C

# Drug_Target_1_Protein_Sequence:
>Glyceraldehyde-3-phosphate dehydrogenase, glycosomal
MPIKVGINGFGRIGRMVFQALCEDGLLGTEIDVVAVVDMNTDAEYFAYQMRYDTVHGKFK
YEVTTTKSSPSVAKDDTLVVNGHRILCVKAQRNPADLPWGKLGVEYVIESTGLFTAKAAA
EGHLRGGARKVVISAPASGGAKTLVMGVNHHEYNPSEHHVVSNASCTTNCLAPIVHVLVK
EGFGVQTGLMTTIHSYTATQKTVDGVSVKDWRGGRAAAVNIIPSTTGAAKAVGMVIPSTQ
GKLTGMSFRVPTPDVSVVDLTFTAARDTSIQEIDAALKRASKTYMKGILGYTDEELVSAD
FINDNRSSIYDSKATLQNNLPKERRFFKIVSWYDNEWGYSHRVVDLVRHMASKDRSARL

# Drug_Target_1_Reaction:
D-glyceraldehyde 3-phosphate + phosphate + NAD+ = 3-phospho-D-glyceroyl phosphate + NADH + H+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
D-glyceraldehyde 3-phosphate + phosphate + NAD(+) = 3-phospho-D-glyceroyl phosphate + NADH

# Drug_Target_1_SwissProt_ID:
P22513

# Drug_Target_1_SwissProt_Name:
G3PG_TRYCR

# Drug_Target_1_Synonyms:
EC 1.2.1.12
GAPDH

# Drug_Target_1_Theoretical_pI:
9.01

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
GAPDHS

# Drug_Target_2_GenBank_ID_Gene:
AJ005371

# Drug_Target_2_GenBank_ID_Protein:
3046742

# Drug_Target_2_GeneCard_ID:
GAPDHS

# Drug_Target_2_Gene_Name:
GAPDHS

# Drug_Target_2_Gene_Sequence:
>1227 bp
ATGTCGAAGCGCGACATCGTCCTCACCAATGTCACCGTTGTCCAGTTGCTGCGACAGCCG
TGCCCGGTGACCAGAGCACCGCCCCCACCTGAGCCTAAGGCTGAAGTAGAGCCCCAGCCA
CAACCAGAGCCCACACCAGTCAGGGAGGAAATAAAGCCACCACCGCCACCACTGCCTCCT
CACCCCGCTACTCCTCCTCCTAAGATGGTGTCTGTGGCCCGGGAGCTGACTGTGGGCATC
AATGGATTTGGACGCATCGGTCGCCTGGTCCTGCGCGCCTGCATGGAGAAGGGTGTTAAG
GTGGTGGCTGTGAATGATCCATTCATTGACCCGGAATACATGGTGTACATGTTTAAGTAT
GACTCCACCCACGGCCGATACAAGGGAAGTGTGGAATTCAGGAATGGACAACTGGTCGTG
GACAACCATGAGATCTCTGTCTACCAGTGCAAAGAGCCCAAACAGATCCCCTGGAGGGCT
GTCGGGAGCCCCTACGTGGTGGAGTCCACAGGCGTGTACCTCTCCATACAGGCAGCTTCG
GACCACATCTCTGCAGGTGCTCAACGTGTGGTCATCTCCGCGCCCTCACCGGATGCACCA
ATGTTCGTCATGGGTGTCAATGAAAATGACTATAACCCTGGCTCCATGAACATTGTGAGC
AACGCGTCCTGCACCACCAACTGTTTGGCTCCCCTCGCCAAAGTCATCCACGAGCGATTT
GGGATCGTGGAAGGGTTGATGACCACAGTCCATTCCTACACGGCCACCCAGAAGACAGTG
GACGGGCCATCAAGGAAGGCCTGGCGAGATGGGCGGGGTGCCCACCAGAACATCATCCCA
GCCTCCACTGGGGCTGCGAAAGCTGTGACCAAAGTCATCCCAGAGCTCAAAGGGAAGCTG
ACAGGGATGGCGTTCCGGGTACCAACCCCGGATGTGTCTGTCGTGGACCTGACCTGCCGC
CTCGCCCAGCCTGCCCCCTACTCAGCCATCAAGGAGGCTGTAAAAGCAGCAGCCAAGGGG
CCCATGGCTGGCATCCTTGCCTACACCGAGGATGAGGTCGTCTCTACGGACTTCCTCGGT
GATACCCACTCGTCCATCTTCGATGCTAAGGCCGGCATTGCGCTCAATGACAATTTCGTG
AAGCTCATTTCATGGTACGACAACGAATATGGCTACAGTCACCGGGTGGTCGACCTCCTC
CGCTACATGTTCAGCCGAGACAAGTGA

# Drug_Target_2_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_2_General_References:
10714828	Welch JE, Brown PL, O'Brien DA, Magyar PL, Bunch DO, Mori C, Eddy EM: Human glyceraldehyde 3-phosphate dehydrogenase-2 gene is expressed specifically in spermatogenic cells. J Androl. 2000 Mar-Apr;21(2):328-38.

# Drug_Target_2_HGNC_ID:
HGNC:24864

# Drug_Target_2_HPRD_ID:
13566

# Drug_Target_2_ID:
794

# Drug_Target_2_Locus:
19q13.1

# Drug_Target_2_Molecular_Weight:
44502

# Drug_Target_2_Name:
Glyceraldehyde-3-phosphate dehydrogenase, testis-specific

# Drug_Target_2_Number_of_Residues:
408

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00044	Gp_dh_N
PF02800	Gp_dh_C

# Drug_Target_2_Protein_Sequence:
>Glyceraldehyde-3-phosphate dehydrogenase, testis-specific
MSKRDIVLTNVTVVQLLRQPCPVTRAPPPPEPKAEVEPQPQPEPTPVREEIKPPPPPLPP
HPATPPPKMVSVARELTVGINGFGRIGRLVLRACMEKGVKVVAVNDPFIDPEYMVYMFKY
DSTHGRYKGSVEFRNGQLVVDNHEISVYQCKEPKQIPWRAVGSPYVVESTGVYLSIQAAS
DHISAGAQRVVISAPSPDAPMFVMGVNENDYNPGSMNIVSNASCTTNCLAPLAKVIHERF
GIVEGLMTTVHSYTATQKTVDGPSRKAWRDGRGAHQNIIPASTGAAKAVTKVIPELKGKL
TGMAFRVPTPDVSVVDLTCRLAQPAPYSAIKEAVKAAAKGPMAGILAYTEDEVVSTDFLG
DTHSSIFDAKAGIALNDNFVKLISWYDNEYGYSHRVVDLLRYMFSRDK

# Drug_Target_2_Reaction:
D-glyceraldehyde 3-phosphate + phosphate + NAD+ = 3-phospho-D-glyceroyl phosphate + NADH + H+

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
May play an important role in regulating the switch between different pathways for energy production during spermiogenesis and in the spermatozoon. Required for sperm motility and male fertility

# Drug_Target_2_SwissProt_ID:
O14556

# Drug_Target_2_SwissProt_Name:
G3PT_HUMAN

# Drug_Target_2_Synonyms:
EC 1.2.1.12
GAPDH-2
Spermatogenic cell-specific glyceraldehyde 3-phosphate dehydrogenase 2
Spermatogenic glyceraldehyde-3-phosphate dehydrogenase

# Drug_Target_2_Theoretical_pI:
8.34

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB02205
